Please login to view this media
- Talk
- 19/09/2023
- UK
BAJIS - ICM 18 OR EBJIS 21: Which Diagnostic Criteria for PJI Should We Go With?
Description
In this presentation, Pedro Foguet discusses the evolution of diagnostic criteria for periprosthetic joint infections (PJI) since the 2013 International Consensus Meeting (ICM) standards and the emergence of the 2018 ICM and 2021 European Bone and Joint Infection Society (EBJIS) guidelines. He highlights the importance of a standardized definition of PJI for collaboration and research, mentioning the poor consensus on these definitions during meetings. Foguet addresses the validation differences of the two most recent sets of criteria, emphasizing that while the ICM 2018 was based on expert opinion, the EBJIS 2021 utilized a more structured validation process.
Foguet points out the new classification elements introduced by the EBJIS 2021, such as scoring for minor criteria and the concept of collinearity, which aims to streamline testing for clinicians. He expresses concerns regarding the accessibility of certain tests in the UK, noting that some recommended procedures might not be available or practical in various regions. Additionally, he tackles the challenges of diagnosing culture-negative infections and highlights the necessity of involving histopathologists who are not always available or interested in infection cases.
Towards the end of the talk, Foguet prompts an evaluation of which set of diagnostic criteria is more effective in the clinical context and encourages attendees to apply a thoughtful approach to using these tools. He suggests starting with basic inflammatory markers and joint aspirations before considering extensive tests, reinforcing the importance of clinical history and examination in reaching a diagnosis. He concludes with a nod toward future advances in molecular diagnostics and a call for improved histopathological engagement in infection diagnostics.